Philip is a co-founder of cannmedic and served as the company’s managing director for five years. With a degree in medical technology and molecular biology, specializing in neuroscience and focusing on cannabinoids, he is recognized as an expert in the medical application of cannabinoids. As a medical device consultant, he led cannmedic’s sales efforts and provides specialized consulting services to the medical community. His expertise encompasses the development and distribution of cannabinoid-based products. In the field of research, he participates in significant basic research at the Center for Brain Research at the Medical University of Vienna. As a co-founder of cannhelp GmbH, a pioneer in the CBD sector, he has many years of entrepreneurial experience. In addition, he maintains an extensive network within the industry and advises internationally active companies in the field of medical cannabinoids.
Thomas is the CEO of cannhelp GmbH, and in this role, he brings a wide range of expertise gained from more than a decade as an entrepreneur in the healthcare sector. His passion for innovative solutions, combined with his extensive entrepreneurial experience, provides a focused direction for marketing and sales. Effectively promoting these innovative health solutions across the appropriate channels is a key factor in positioning CANNEFF products as a leading brand for CBD medical products and further expanding their reach among relevant target audiences. Thomas has been actively involved in the CBD sector for more than 10 years, working in a variety of roles.
The German-speaking world needs legally compliant and authorised cannabinoid-based products. We offer an effective and natural method for the relief of numerous indications in the field of gynaecology & urology & general medicine. The positive effects, based on the combination of hyaluronic acid and cannabidiol, can effectively solve many of these needs in gynaecology, urology, internal medicine & surgery. We further are actively involved in the international Business Development of CANNEFF CBD suppositories.